{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:03:26Z","timestamp":1761919406063},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.mehy.2010.09.015","type":"journal-article","created":{"date-parts":[[2010,10,18]],"date-time":"2010-10-18T01:56:18Z","timestamp":1287366978000},"page":"190-193","source":"Crossref","is-referenced-by-count":24,"title":["Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome"],"prefix":"10.1016","volume":"76","author":[{"given":"B.","family":"Ben-Zeev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Aharoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nissenkorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Arnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2010.09.015_b0005","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/sj.ejhg.5201580","article-title":"Rett syndrome: clinical review: new clinical and molecular insights","volume":"14","author":"Weaving","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.mehy.2010.09.015_b0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.410140412","article-title":"A progressive syndrome of autism, dementia, ataxia and loss of purposeful hand use in girls: Rett syndrome: report of 35 cases","volume":"14","author":"Hagberg","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2010.09.015_b0015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0092-8674(00)81887-5","article-title":"MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin","volume":"88","author":"Nan","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2010.09.015_b0020","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1074\/jbc.M210256200","article-title":"The Methyl CpG binding protein MeCP2 links DNA methylation to histone methylation","volume":"278","author":"Fuks","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2010.09.015_b0025","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and repress transcription","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.mehy.2010.09.015_b0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of Methyl CpG binding protein-2 in CNS neurons results in Rett like phenotype in mice","volume":"27","author":"Chen","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.mehy.2010.09.015_b0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","article-title":"Mice with truncated MECP2 recapitulate many Rett syndrome features and display hyperacetylation of Histone H3","volume":"35","author":"Shabbazian","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2010.09.015_b0040","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in mouse model of Rett syndrome","volume":"315(5815)","author":"Guy","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.mehy.2010.09.015_b0045","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0896-6273(95)90085-3","article-title":"Neurotrophic factors and synaptic plasticity","volume":"15","author":"Lo","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2010.09.015_b0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0079-6123(00)28016-3","article-title":"Neurotrophins and activity dependent plasticity","volume":"128","author":"Thoenen","year":"2000","journal-title":"Prog Brain Res"},{"issue":"5646","key":"10.1016\/j.mehy.2010.09.015_b0055","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.1086446","article-title":"De-repression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2","volume":"302","author":"Chen","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.mehy.2010.09.015_b0060","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1090842","article-title":"DNA methylation related chromatin remodeling in activity dependent BDNF gene regulation","volume":"302","author":"Martinowich","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.mehy.2010.09.015_b0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2010.09.015_b0070","doi-asserted-by":"crossref","DOI":"10.1113\/jphysiol.2009.169805","article-title":"Remodelling of the respiratory network in a mouse model of Rett syndrome depends on Brain Derived Neurotrophic factor regulated slow calcium buffering","volume":"587","author":"Mironov","year":"2009","journal-title":"J Physiol"},{"key":"10.1016\/j.mehy.2010.09.015_b0075","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1523\/JNEUROSCI.1810-06.2006","article-title":"Dysregulation of Brain derived neurotrphic factor expression and neurosecretory function in MeCP2 null mice","volume":"26","author":"Wang","year":"2006","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.mehy.2010.09.015_b0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nbd.2008.12.011","article-title":"Bdnf overexpression in hyppocampal neurons prevents dendritic atrophy caused by Rett associated MECP2 mutations","volume":"34","author":"Larimore","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"10","key":"10.1016\/j.mehy.2010.09.015_b0085","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/08830738030180101101","article-title":"Neurotrophic factors in the pathogenesis of Rett syndrome","volume":"18","author":"Riikonen","year":"2003","journal-title":"J Child Neurol"},{"issue":"4","key":"10.1016\/j.mehy.2010.09.015_b0090","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/epi.2.4.5212","article-title":"MeCP2 deficiency in the brain decreases BDNF level by REST\/CoREST mediated repression and increases TRKB production","volume":"2","author":"Abuhatzira","year":"2007","journal-title":"Epigenetics"},{"issue":"2","key":"10.1016\/j.mehy.2010.09.015_b0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.mehy.2010.09.015_b0100","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1523\/JNEUROSCI.0348-04.2004","article-title":"Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons","volume":"24","author":"Chen","year":"2004","journal-title":"J Neurosci"},{"issue":"45","key":"10.1016\/j.mehy.2010.09.015_b0105","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.1523\/JNEUROSCI.2680-04.2004","article-title":"The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology","volume":"24","author":"Pezawas","year":"2004","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.mehy.2010.09.015_b0110","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ajmg.b.30619","article-title":"BDNF Val66Met variant and age of onset in schizophrenia","volume":"147B","author":"Chao","year":"2007","journal-title":"Am J Med Genet B"},{"issue":"12","key":"10.1016\/j.mehy.2010.09.015_b0115","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1176\/appi.ajp.2007.05111903","article-title":"Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia","volume":"164","author":"Ho","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.mehy.2010.09.015_b0120","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.mp.4002044","article-title":"Temporal grey matter reductions in bipolar disorder are associated with the BDNF Val66Met polymorphism","volume":"12","author":"McIntosh","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2010.09.015_b0125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1192\/bjp.bp.105.010587","article-title":"Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study","volume":"189","author":"Muller","year":"2006","journal-title":"Br J Psychiatry"},{"issue":"9","key":"10.1016\/j.mehy.2010.09.015_b0130","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.neurobiolaging.2007.11.023","article-title":"Role of BDNF Val66Met functional polymorphism in Alzheimer\u2019s disease-related depression","volume":"30","author":"Borroni","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.mehy.2010.09.015_b0135","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000345664.72220.6a","article-title":"The common BDNF polymorphism may be a modifier of disease severity in Rett Syndrome","volume":"72","author":"Ben-Zeev","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2010.09.015_b0140","doi-asserted-by":"crossref","unstructured":"Nissenkorn A., Gak E., Vecksler M., Reznik H., Menascu S., Ben-Zeev B. Epilepsy in Rett syndrome - the experience of a National Rett Centre. Epilepsia 2010 accepted for publication.","DOI":"10.1111\/j.1528-1167.2010.02597.x"},{"issue":"40","key":"10.1016\/j.mehy.2010.09.015_b0145","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1523\/JNEUROSCI.1869-07.2007","article-title":"Brain derived neurotrophic factor expression and respiratory function improve after Ampakine treatmnent in a mouse model for Rett syndrome","volume":"27","author":"Ogier","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2010.09.015_b0150","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/240564b0","article-title":"Protection against allergic encephalomyelitis","volume":"240","author":"Teilelbaum","year":"1972","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2010.09.015_b0155","first-page":"280","article-title":"Copolymer 1: from the laboratory to FDA.Is","volume":"33","author":"Teitelbaum","year":"1997","journal-title":"J Med Sci"},{"key":"10.1016\/j.mehy.2010.09.015_b0160","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/brain\/awf252","article-title":"Glatiramer acetate specific T helper1 and 2 type cell lines produce BDNF: implication for multiples sclerosis therapy","volume":"125","author":"Ziemssen","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.mehy.2010.09.015_b0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-510X(03)00177-1","article-title":"Glatiramer acetate reactive T cell produce brain derieved neurotrophic factor","volume":"215","author":"Chen","year":"2003","journal-title":"J Neurol Sci"},{"issue":"24","key":"10.1016\/j.mehy.2010.09.015_b0170","doi-asserted-by":"crossref","first-page":"14157","DOI":"10.1073\/pnas.2336171100","article-title":"Glatiramer acetate specific T cells in the brain express T helper 2\/3 cytokines and brain derived neurotrophic factor in situ","volume":"100","author":"Ahroni","year":"2003","journal-title":"PNAS"},{"issue":"52","key":"10.1016\/j.mehy.2010.09.015_b0175","doi-asserted-by":"crossref","first-page":"19045","DOI":"10.1073\/pnas.0509438102","article-title":"The immunomodulator glatirmaer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice","volume":"102","author":"Ahroni","year":"2005","journal-title":"PNAS"},{"issue":"36","key":"10.1016\/j.mehy.2010.09.015_b0180","first-page":"8217","article-title":"Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of Experimental Autoimmune Encephalomyelitis","volume":"25","author":"Ahroni","year":"2005","journal-title":"J Neuro science"},{"key":"10.1016\/j.mehy.2010.09.015_b0185","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1002\/eji.200737398","article-title":"T cell independent mechanism for copolymer1 induced neuroprotection","volume":"37","author":"Liu","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.mehy.2010.09.015_b0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jneuroim.2005.07.001","article-title":"Lower brain derived neurotrophic factor in serum of relapsing remitting MS: reversal by Glatiramer Acetate","volume":"167","author":"Azoulay","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2010.09.015_b0195","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neulet.2006.07.043","article-title":"Effect of glatiramer acetate on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: A longitudinal study","volume":"406","author":"Blanco","year":"2006","journal-title":"Neurosci lett"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2010.09.015_b0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-4328(02)00082-7","article-title":"Frontal cortex BDNF levels correlate with working memory in an animla model of Down syndrome","volume":"139","author":"Bimonte-Nelson","year":"2003","journal-title":"Behav Brain Res"},{"issue":"40","key":"10.1016\/j.mehy.2010.09.015_b0205","doi-asserted-by":"crossref","first-page":"10685","DOI":"10.1523\/JNEUROSCI.2624-07.2007","article-title":"Brain Derived Neurotrophic factor rescue synaptic plasticity in a mouse model of Fragile X syndrome","volume":"27","author":"Lauterborn","year":"2007","journal-title":"J Neuroscience"},{"key":"10.1016\/j.mehy.2010.09.015_b0210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.mehy.2006.10.051","article-title":"Glatiramer acetate could be a potential antidepressant through its neuroprotective and anti-inflammatory effects","volume":"69","author":"Tsai","year":"2007","journal-title":"Med Hypothesis"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987710003695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987710003695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T11:30:19Z","timestamp":1559734219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987710003695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0306987710003695"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2010.09.015","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}